- Home
- / Zhejiang Huahai Pharmaceutical
Zhejiang Huahai Pharmaceutical
Stock Price
¥18.8
2024-10-29
Market Capitalization
¥27.1 B
2024-10-29
Revenue
¥8.4 B
FY, 2025
Zhejiang Huahai Pharmaceutical Summary
Company Summary
- Overview
- Zhejiang Huahai Pharmaceutical (浙江华海药业股份有限公司) is a pharmaceutical company that manufactures and distributes medicinal and health products. Its products cover the cardiovascular, central nervous system, anti-viral, etc.
- Type
- Public
- Status
- Active
- Founded
- 1989
- HQ
- Taizhou, CN | view all locations
- Website
- https://en.huahaipharm.com
Table of Contents
LocationsView all
4 locations detected
Taizhou, Zhe Jiang Sheng HQ
China
104 National Road
Franklin, NJ
United States
700 atrium Dr
Hangzhou, Zhe Jiang Sheng
China
23rd-24th Floor, Block B, Zhonghai-Huanyu Business Center, No. 626, Kejiguan Street
Munich, BY
Germany
Werner-Eckert-Strasse 4
Zhejiang Huahai Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥2.3B
- Gross profit (Q1, 2026)
- ¥1.3B
- Net income (Q1, 2026)
- ¥398.3M
- Cash (Q1, 2026)
- ¥1.9B
- EBIT (Q1, 2026)
- ¥305.0M
- Enterprise value
- $34.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026